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Soluble fibronectin induces chemokine gene expression in renal
tubular epithelial cells.
Background. Increasing proteinuria in kidney disease is asso-
ciated with an increased risk of renal failure. Urinary proteins
such as albumin induce inflammatory signaling and gene ex-
pression in tubular epithelial cells (TECs). Fibronectin is an
extracellular matrix protein that can exist in soluble form and
is excreted in the urine of patients with glomerular disease.
Methods. To explore the impact of soluble fibronectin on
tubular epithelium, murine TECs were stimulated with soluble
fibronectin and chemokine mRNA was determined by RNase
protection assay.
Results. Fibronectin induced the expression of inflammatory
chemokine genes, including monocyte chemoattractant protein-
1 (MCP-1) (CCL2) and macrophage inflammatory protein-2
(MIP-2) within 2 hours in a dose-dependent manner. Phospho-
rylation of Src family tyrosine kinases was also increased in
TECs following exposure to fibronectin. Src tyrosine kinases
were involved in the fibronectin activation of MCP-1 since the
Src inhibitors SU6656 and PP2 effectively reduced the induction
of this chemokine. Fibronectin also induced the phosphoryla-
tion of extracellular signal-regulated protein kinase (ERK1/2)
within minutes in TECs. The ERK kinase (MEK1/2) inhibitor
U0126 inhibited the fibronectin induction of MCP-1 mRNA
suggesting that ERK1/2 was also involved in this inflammatory
pathway. Furthermore, fibronectin also induced phosphoryla-
tion of IjBa within 20 minutes in TECs. The nuclear factor-
kappaB (NF-jB) inhibitors N-acetyl-L-cysteine (NAC) and
pyrrolidinecarbodithioic acid (PDTC) effectively blocked fi-
bronectin induction of MCP-1 mRNA.
Conclusion. Soluble fibronectin activates MCP-1 gene ex-
pression in TECs via Src tyrosine kinases, ERK1/2 and NF-jB.
These data provide further support to the concept that protein-
uria per se contributes to the tubulointerstitial injury observed
in glomerular disease.
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The incidence of end-stage renal disease (ESRD) is on
the rise. The expanding population of patients in need
of renal replacement is associated with significant cost to
health care and society. Furthermore, ESRD has a poor
prognosis with a 5-year survival of less than 50% for non-
diabetic patients over the age of 50 years [1]. One strategy
to reduce the number of patients requiring renal replace-
ment therapy is to slow or prevent the progression in
patients with established kidney disease. A thorough un-
derstanding of the biology of progressive kidney disease
is required to devise specific therapies to achieve this goal.
In nondiabetic kidney disease, the severity of protein-
uria correlates with an increased risk of renal failure [2, 3].
Increasing proteinuria is often associated with tubuloin-
terstitial disease that consists of fibrosis and inflamma-
tion [4]. The secretion of chemokines such as monocyte
chemoattractant protein (MCP-1) (CCL2) by tubular ep-
ithelial cells (TECs) and other cell types is central to the
process and is increased in many chronic nephropathies
[5–7]. Chemokines facilitate the recruitment of leuko-
cytes to the injured kidney [8–12]. These inflammatory
cells in turn secrete cytokines [e.g., transforming growth
factor-b (TGF-b)] and growth factors [e.g., fibroblast
growth factor-2 (FGF-2)] that induce the production of
extracellular matrix proteins such as fibronectin and col-
lagen [13–17]. A destructive cycle of inflammation and
fibrosis is created that results in progressive kidney fail-
ure. The importance of chemokine induction in progres-
sive renal injury is established since blocking MCP-1
improves renal injury in experimental models, including
protein overload nephropathy [18]. The factors that ac-
tivate TECs to express chemokine genes such as MCP-
1 are numerous. Over the past few years, the effect of
proteinuria and its constituents on renal tubular epithe-
lium has been examined. Several proteins excreted in the
urine of patients with glomerular disease, including albu-
min and transferrin induce the expression of chemokine
genes in renal tubular cells [4, 19–22]. The induction of
chemokines such as MCP-1 and regulated upon activa-
tion, normal T-cell expressed and secreted (RANTES) in-
volves signal activation via the mitogen-activated protein
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kinases (MAPK) such as extracellular signal-regulated
protein kinase (ERK1/2) and p38 MAPK. In addition,
the activation of nuclear factor-kappaB (NF-jB) plays a
central role in regulating the expression of these inflam-
matory genes [4, 23, 24]. The evidence strongly suggests
that proteinuria induces an inflammatory response in re-
nal tubular epithelium that contributes to renal failure.
Fibronectin is a large extracellular matrix glycopro-
tein that exists as a dimer. Soluble fibronectin is present
in plasma and various body fluids, whereas cellular fi-
bronectin is confined to tissues. In the normal kidney, cel-
lular fibronectin is expressed primarily in the mesangium
and lamina rara of the glomerular basement membrane
(GBM) [25]. In disease states, cellular fibronectin is in-
creased in the glomerulus and the tubulointerstitium of
the kidney and is a significant component of renal fibrosis
[26–29]. Soluble fibronectin is also reported in clinical and
experimental renal disease. Urinary fibronectin levels
are increased in patients with diabetic nephropathy and
glomerular diseases, including membranous nephropathy
[30–34]. Soluble fibronectin is also seen in the tubular lu-
men and urine of rats in various experimental models of
renal injury [28, 35, 36]. While cellular fibronectin has di-
verse biologic functions with respect to fibrosis, the role of
soluble and urinary fibronectin is less clear. Fibronectin
is associated with inflammation [25]. It is expressed by
leukocytes and most cell types, including mesangial and
TECs in response to cytokines and growth factors such
as TGF-b [16, 17, 37]. Fibronectin is required for optimal
adhesion of neutrophils, monocytes, and macrophages
to sites of injury. Various proteolytic fragments of fi-
bronectin can also mediate leukocyte chemotaxis [25, 38–
40]. In addition to these effects, fibronectin can activate
cells to secrete growth factors and cytokines and can acti-
vate and enhance the phagocytic ability of macrophages
[25, 41, 42]. Thus, soluble fibronectin may contribute to
the inflammatory tubular response to proteinuria seen in
glomerular disease.
Understanding the biology of progressive renal dis-
ease is essential to identify potential therapeutic targets
to stem the tide of ESRD. In this study, we explore the ef-
fect of soluble fibronectin on chemokine gene expression
in renal TECs, a key aspect of tubulointerstitial injury in
kidney diseases associated with proteinuria.
METHODS
TEC isolation and cell culture
Primary cultures of renal TECs were prepared from
male C57/B6 mice (Charles River Laboratory, Wilm-
ington, MA, USA) as described [43]. Cells were grown
on collagen type IV–coated (Sigma Chemical Co., St.
Louis, MO, USA) tissue culture plates in K1 media [Dul-
becco’s modified Eagle’s medium (DMEM)/Ham F-12
(50:50), Hepes 25 mmol/L, 1% penicillin/streptomycin
supplemented with insulin-transferrin-sodium selenite
(0.12 IU/mL), prostaglandin E1 (PGE1) 1.25 ng/mL, L-
thyroxine 34 pg/mL, hydrocortisone 18 ng/mL, and epi-
dermal growth factor (EGF) 2.5 pg/mL (Sigma Chemical
Co.)] containing 10% fetal bovine serum (FBS).
Fibronectin and inhibitor studies
All experiments were performed using TECs (passage
5 or less) at 100% confluence in serum-starved condi-
tions (K1 containing 0.1% FBS). Unless otherwise spec-
ified, TECs were stimulated with 100 ug/mL of soluble
bovine fibronectin (Sigma Chemical Co.), purified colla-
gen type I (Sigma Chemical Co.) or mock-stimulated us-
ing an equivalent volume of buffer (0.5 mmol/L NaCl and
50 mmol/L Tris, pH 7.5). Specific concentrations of the
chemical inhibitors N-acetyl-L-cysteine (NAC), pyrro-
lidinecarbodithioic acid (PDTC) (Sigma Chemical Co.),
U0126, U0124, PP2, PP3, and SU6656 (CalBiochem, San
Diego, CA, USA) were added to cells 30 minutes prior
to the addition fibronectin.
Immunocytochemistry and fluorescence microscopy
To confirm epithelial phenotype, TECs were stained
for cytokeratin, the tight junction protein zona occludens-
1 (ZO-1) and the adherens junction protein E-cadherin
using a mouse pan-cytokeratin antibody (Sigma Chem-
ical Co.), rat antimouse ZO-1 antibody (clone R40.76)
(Chemicon, Temecula, CA, USA) and mouse antimouse
E-cadherin antibody (clone 36) (BD Pharmingen, San
Diego, CA, USA), respectively. Acetone-fixed TECs
were incubated with primary antibodies for 1 hour
and secondary species-specific AlexaFluor 488–labeled
IgG antibody for 30 minutes. Fluorescent microscopy
was performed and images captured using an Olym-
pus IX70 inverted microscope. Staining for the prox-
imal tubule-specific brush border enzyme c-glutamyl
transpeptidase was performed by enzymatic reac-
tion. TECs were incubated with reaction buffer con-
taining L-glutamic acid-c-(4-methoxy-b-naphthylamide)
200 lmol/L, glycine-glycine 3.5 mmol/L, and fast blue
BB salt, 600 lmol/L (Sigma Chemical Co.) for 2 hours.
Cells were washed and then incubated in copper sulfate
150 mmol/L for 2 minutes.
Endotoxin removal and testing
All buffers and fibronectin were tested for the
presence of endotoxin using the limulus amebocyte
lysate kit (Cambrex, East Rutherford, NJ, USA) as
per the manufacturer’s protocol. Most fibronectin
preparations were found to contain varying levels of
endotoxin (up to 10 EU/mL in some cases). Experiments
were performed in the presence of polymyxin B (50
ug/mL) or fibronectin was cleared of endotoxin using
polymyxin B–immobilized columns (Detoxi-GelTM)
(Pierce Chemical, Rockford, IL, USA) as per the
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Fig. 1. Characterization of primary tubular
epithelial cells (TECs). Immunofluorescence
microscopy (60× magnification). (A) Cytok-
eratin. (B) E-cadherin. (C) Zona occludens-1
(ZO-1). (D) Staining for the proximal tubule
cell enzyme c-glutamyl transpeptidase [un-
stained (left panel) and stained (right panel)
TECs].
manufacturer’s protocol. Protein integrity of eluted
fibronectin (in 0.5 mmol/L NaCl and 50 mmol/L Tris,
pH 7.5) was confirmed by Coomassie-stained sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Cleared reagents contained <0.1 EU/mL
of endotoxin as determined by the limulus amebocyte
lysate assay.
RNase protection assay
Cells were processed for total RNA using RNeasy
(Qiagen, Chatsworth, CA, USA) as per protocol. RNase
protection assays were performed using the RiboQuant
Multi-Probe RNase Protection Assay System (Pharmin-
gen) and the mCK5 template set as per the man-
ufacturer’s protocol. Protected samples were realized
on acrylamide:bis-acrylamide urea gels and visualized
by phosphoimaging using the Bio-Rad Personal FX
Molecular Imager and Quantity One software (Bio-Rad,
Hercules, CA, USA).
Immunoblotting
TECs were stimulated with fibronectin for specified
time points and lysed directly with lysis buffer [50 mmol/L
Tris-HCl, pH 7.4, 150 mmol/L NaCl, 1% NP-40 with
1 mmol/L Na3VO4, 1 mmol/L phenylmethylsulfonyl flu-
oride (PMSF), 10 lg/mL each of aprotinin and leupeptin,
and 1 mmol/L NaF]. Lysate protein concentration was
determined with the Bradford assay. Equivalent amounts
of protein were separated on a 10% SDS-PAGE gel then
transferred to a polyvinyldine difluoride (PVDF) mem-
brane. Membranes were blocked with skim milk and
incubated overnight with 1:1000 dilution of antibodies
against phosphorylated and total p44/42 ERK, phospho-
rylated pan-Src tyrosine kinase, phosphorylated and to-
tal IjBa (Cell Signaling Inc., Beverly, MA, USA), or b-
actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Membranes were then incubated for 1 hour with 1:2000
dilution of peroxidase-conjugated secondary antibodies.
Proteins were visualized using enhanced chemilumines-
cence (ECL) substrate reagent (Amersham Pharmacia,
Piscataway, NJ, USA) and quantified by chemilumines-
cence using the Chemi-Doc Apparatus and Quantity-
One software (Bio-Rad).
Statistical analysis
All experiments were performed at least in trip-
licate. Relative gene expression was determined as
mRNA density ratio (as determined by phosphoimag-
ing) of the expressed gene to the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
within the same sample. Protein phosphorylation was de-
termined based on chemiluminescence density ratio of
the phosphorylated protein to total protein or b-actin
control within the same sample. Values are expressed as
the mean ± SEM and compared using the Student t test.
RESULTS
Characterization of TECs
Primary cultures of mouse renal TECs were em-
ployed in our studies using the established technique de-
scribed by Wuthrich et al [43]. To further characterize
and confirm the epithelial nature of these primary cell
cultures, immunofluorescence and histochemical experi-
ments were performed. Immunofluorescence for the ep-
ithelial marker, cytokeratin revealed widespread (>90%)
staining in TECs similar to results described by other
groups [43, 44] (Fig. 1A). Next, to assess cell polarity,
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Fig. 2. Fibronectin induced chemokine expression in tubular epithelial cells (TECs). (A) RNase protection assay of TECs total RNA 6 hours
following stimulation with increasing concentration of fibronectin. (B) Chemokine and monocyte chemoattractant protein-1 (MCP-1) mRNA
expression time course in fibronectin stimulated TECs (RNase protection assay). Images representative of experiments performed at least three
times. Abbreviations are: RANTES, regulated upon activation, normal T-cell expressed and secreted; MIP-2, macrophage inflammatory protein-2;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IP-10, interferon-inducible protein-10.
immunocytochemistry for the tight junction protein, ZO-
1, and the adherens junction protein, E-cadherin was
performed. Both ZO-1 and E-cadherin were highly ex-
pressed at TEC-cell junctions confirming that these ep-
ithelial cells remain polarized in cell culture (Fig. 1B
and C). Finally, to assess the relative number of proxi-
mal tubular cells, staining for the proximal tubular cell
brush border enzyme c-glutamyl transpeptidase was per-
formed. More than 90% of cells in culture stained pos-
itive for c-glutamyl transpeptidase confirming that the
cells were proximal tubular in origin (Fig. 1D). A num-
ber of cells (<10%) lacked c-glutamyl transpeptidase
staining, but still expressed cytokeratin and formed tight
junctions, implying a small population of distal tubu-
lar cells. In contrast to the positive staining seen in low
passage TECs, high passage TECs (>10) stained nega-
tive for cytokeratin, E-cadherin, ZO-1, and c-glutamyl
transpeptidase consistent with a myofibroblast pheno-
type (data not shown). These data confirm that pri-
mary cultures of TECs are polarized proximal tubular
cells.
Chemokine induction by soluble fibronectin
Fibronectin is excreted in the urine of patients with
proteinuria and glomerular disease such as membra-
nous nephropathy [30–33]. To determine the potential
proinflammatory effect of this protein on renal epithe-
lium, confluent monolayers of TECs were exposed to
increasing concentrations of soluble fibronectin (50 to
150 lg/mL). At 6 hours, total cell RNA was harvested and
analyzed by RNase protection assay. Although numer-
ous chemokine transcripts were measured, only MCP-1
and macrophage inflammatory protein-2 (MIP-2) were
consistently induced by soluble fibronectin compared to
mock-treated cells (Fig. 2A). Furthermore, the induction
of MCP-1 and MIP-2 mRNA occurred as early as 2 hours
following fibronectin stimulation (Fig. 2B).
MIP-2 is a murine C-X-C chemokine with no specific
human homologue and thus its role in kidney disease is
unclear. In contrast, MCP-1 is a C-C chemokine that has
been implicated in the pathogenesis of kidney disease
and tubulointerstitial injury, especially in response to pro-
teinuria [5–7]. For this reason, the expression of MCP-1
Ren et al: Fibronectin-induced inﬂammation 2115
Firbonectin
(µg/mL)
0 50 100 150
MCP-1
Actin
MCP-1
GAPDH
Mo
ck
Fib
ron
ec
tin
Co
llag
enA B
Fig. 3. Fibronectin induced monocyte
chemoattractant protein-1 (MCP-1) gene
expression in tubular epithelial cells (TECs).
(A) MCP-1 protein expression following
fibronectin dose-response in TECs (im-
munoblot). (B) Effect of type I collagen
stimulation on MCP-1 gene expression in
TECs (RNase protection assay). Images
representative of experiments performed at
least three times. GAPDH is glyceraldehyde-
3-phosphate dehydrogenase.
was studied further. To confirm that increased MCP-1
mRNA was associated with an increase in protein transla-
tion, immunoblotting for MCP-1 protein was performed.
TEC lysates contained increased levels of MCP-1 protein
at 6 hours following fibronectin stimulation (Fig. 3A).
Next, to determine if other matrix proteins could stim-
ulate MCP-1 expression, TECs were exposed to type I
collagen. In contrast to effect seen with fibronectin, the
exposure of TECs to 100 ug/mL of soluble type I colla-
gen did not increase MCP-1 gene expression at 6 hours
(Fig. 3B). Taken together, these results show that solu-
ble fibronectin induces early, dose-dependent chemokine
gene expression, including MCP-1 in renal TECs.
Fibronectin induction of MCP-1 involves Src
family tyrosine kinases
The major receptors for extracellular matrix proteins
such as fibronectin are integrins. Src family tyrosine ki-
nases such as c-Src or Fyn mediate downstream signal
transduction originating from integrins [45] and are also
common effectors in many signaling pathways, includ-
ing the MAPK. To determine the role of Src tyrosine
kinases in fibronectin induction of MCP-1, TECs were
stimulated with soluble fibronectin and analyzed for ac-
tivated Src tyrosine kinases at 5, 10, and 20 minutes by
immunoblotting using a phospho-specific pan-Src tyro-
sine kinase antibody. An increase in phosphorylation of
Src family tyrosine kinases was seen as early as 5 min-
utes confirming that fibronectin activated one or more
members of this family of signaling proteins (Fig. 3A).
To determine if Src tyrosine kinases were upstream of
fibronectin-mediated MCP-1 gene expression in TECs,
the Src tyrosine kinase inhibitors, SU6656 [46] and PP2
[47], were employed. Both SU6656 (5 lmol/L) and PP2
(5 lmol/L) but not the control compound PP3 (5 lmol/L)
significantly reduced the fibronectin induction of MCP-
1 mRNA expression at 2 hours compared to untreated
cells (SU6656 or PP2-treated vs. untreated cells) (P <
0.05) (N = 3) (PP3-treated vs. untreated cells) (P = NS)
(Fig. 3B). Although the effects of the Src inhibitors on
MCP-1 gene expression were partial, these results suggest
that Src family tyrosine kinases play a role in fibronectin
induced MCP-1 gene expression in TECs.
Fibronectin induction of MCP-1 requires ERK1/2
The previous studies show that Src family tyrosine ki-
nases play a role in the fibronectin induction of MCP-1.
Signaling to p44/42 ERK is a common pathway down-
stream of integrins and Scr family tyrosine kinases and
may play a role in the activation of chemokines by fi-
bronectin [23, 45]. To determine the role of ERK1/2 in
MCP-1 gene expression by fibronectin, activation of this
kinase was determined in TECs. Cells were once again
stimulated with soluble fibronectin, and cell lysates were
analyzed for phosphorylated ERK1/2 by immunoblotting
using a phospo-specific ERK1/2 antibody. ERK1/2 was
clearly activated at 10 minutes and sustained to 30 min-
utes following exposure to fibronectin (fibronectin vs.
mock-stimulated cells) (P < 0.05) (N = 3) (Fig. 4A). Next,
to determine if Src family tyrosine kinases were upstream
of ERK1/2 in response to fibronectin, ERK1/2 activation
was determined in the presence of the Src tyrosine ki-
nase inhibitor SU6656. Consistent with the effects seen
in the previous experiments, ERK1/2 phosphorylation
was reduced, but not completely inhibited, by SU6656
(5 lmol/L) confirming that Src family tyrosine kinases
mediated in part, fibronectin activation of this kinase
(SU6656 treated vs. untreated cells) (P < 0.05) (N = 3)
(Fig. 4B). Finally, to examine the role of ERK1/2 in MCP-
1 gene expression, the ERK kinase (MEK1/2) inhibitor
U0126 was employed [48]. TECs were preincubated with
1 lmol/L of U0126 or the control compound U0124 and
then exposed to soluble fibronectin. At 2 hours, U0126
but not U0124 completely inhibited MCP-1 mRNA in-
duction by fibronectin (Fig. 4C). These results show that
fibronectin induces ERK1/2 phosphorylation in part, via
Src tyrosine kinases. ERK1/2 activation is essential to the
fibronectin induction of MCP-1.
Role of NF-jB in the fibronectin induction of MCP-1
Chemokines are a family of inducible genes, most of
which are transcriptionally regulated by NF-jB [49]. NF-
jB–dependent gene expression plays a pivotal role in the
induction of chemokines in renal epithelium following
exposure to albumin [4]. To determine the role of NF-
jB in the fibronectin induction of MCP-1 experiments
were performed to detect phosphorylated IjBa, a surro-
gate marker for NF-jB activation. TECs were exposed
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Fig. 4. Role of Src family tyrosine kinases
in fibronectin (FN) induction of mono-
cyte chemoattractant protein-1 (MCP-1). (A)
Src family tyrosine kinase phosphorylation
following stimulation with fibronectin. Im-
munoblotting using a pan-phospho-Src (p-
Src) tyrosine kinase antibody. (B) Role of Src
tyrosine kinase inhibitor SU6656 (5 lmol/L)
or PP2 (5 lmol/L) on fibronectin induction of
MCP-1 mRNA at 2 hours (RNase protection
assay compared to fibronectin alone) (P <
0.05) (N = 3). GAPDH is glyceraldehyde-3-
phosphate dehydrogenase.
to fibronectin and cell lysates were harvested at 10, 20,
30, and 60 minutes. Fibronectin induced IjBa phospho-
rylation that increased over time confirming that NF-jB
was activated (Fig. 5A). To determine the roll of NF-jB in
the fibronectin induction of MCP-1, the NF-jB inhibitors
NAC and PDTC were employed [19]. TECs were exposed
to NAC (50 mmol/L) and PDTC (50 lmol/L) 30 minutes
prior to stimulation with fibronectin. At 2 hours, RNA
was harvested and analyzed for MCP-1 mRNA expres-
sion by RNase protection assay. At 2 hours, both NAC
and PDTC attenuated the fibronectin induction of MCP-
1 (Fig. 5B). These results confirm that NF-jB plays a sig-
nificant role in the induction of MCP-1 by fibronectin.
DISCUSSION
The factors that drive the maladaptive response to re-
nal injury are incompletely understood. In nondiabetic
renal disease, proteinuria correlates with the risk of renal
failure [2]. Furthermore, experimental evidence suggests
that proteinuria per se contributes to tubulointerstitial
disease [4]. In this study we demonstrate that fibronectin
activates renal epithelial cells to express inflammatory
chemokine genes. The fibronectin induction of the C-
C chemokine MCP-1 is dependent on Src family tyro-
sine kinases, ERK1/2, and NF-jB. Therefore, soluble
fibronectin may be another urinary protein that con-
tributes to the tubular injury seen in proteinuric renal
disease.
Several studies have examined the role of fibronectin
substratum on the cellular induction of inflammatory
genes. In monocytes and endothelial cells, cell growth
on fibronectin resulted in the induction of numerous
chemokine genes and inflammatory mediators [50, 51].
Similarly, in mesangial cells, growth on various extra-
cellular matrix proteins, including fibronectin, resulted
in MCP-1 gene expression [52]. Integrins and integrin-
mediated signaling played a significant role mediating
the inflammatory response in these studies. In this study,
we show that TECs also respond to soluble fibronectin.
Therefore, in addition to some of the injurious effects that
cellular/tissue fibronectin may have on renal epithelium,
including changes in cell motility and differentiation [53],
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Fig. 5. Role of extracellular signal-regulated protein kinase (ERK1/2) in fibronectin induction of monocyte chemoattractant protein-1 (MCP-1). (A)
ERK1/2 phosphorylation as determined by immunoblotting in tubular epithelial cells (TECs) following fibronectin (FN) stimulation (compared
to mock treated) (P < 0.05) (N = 3). (B) Effect of Src tyrosine kinase inhibition with SU6656 on ERK1/2 phosphorylation (immunoblot) in
fibronectin-stimulated TECs (fibronectin alone vs. fibronectin and 5 lmol/L SU6656) (P < 0.05) (N = 3). (C) Role of ERK kinase (MEK1/2)
inhibitor U0126 (1 lmol/L) on fibronectin induction of MCP-1 in TECs (RNase protection assay). Representative sample of experiment performed
three times. GAPDH is glyceraldehyde-3-phosphate dehydrogenase.
exposure to soluble fibronectin also results in inflamma-
tory gene expression. Therefore, urinary fibronectin may
contribute to tubulointerstitial injury and renal failure in
kidney diseases associated with proteinuria.
The receptor that mediates the cell response to soluble
fibronectin is not known. Integrins are the natural recep-
tors for extracellular matrix proteins, and b 1 integrins in
particular mediate cellular adhesion to fibronectin [45,
54]. In the absence of injury, renal tubular epithelial cells
express basolateral b 1 integrins in vivo. However, tubu-
lar epithelial integrins have been shown to change their
cellular localization during renal injury in vivo [29, 55,
56]. It is possible therefore that fibronectin might trans-
duce signals in epithelial cells via apical expressed inte-
grins. Alternatively, since extracellular matrix proteins
such as fibronectin undergo proteolytic degradation, a fi-
bronectin fragment cannot be ruled out as the proinflam-
matory mediator in our cell model [25, 41, 57]. Further
studies are required to determine the nature of tubular
epithelial interaction with soluble fibronectin.
Our results confirm that the induction of MCP-1 by fi-
bronectin involves common signaling molecules, includ-
ing Src family tyrosine kinases, ERK1/2, and NF-jB.
These results are similar to the signaling studies per-
formed examining the inflammatory properties of other
urinary proteins, including albumin and transferrin [4, 22,
23]. MCP-1 gene expression was highly dependent on the
MAPK ERK1/2 since the MEK1/2 inhibitor U0126 com-
pletely blocked the fibronectin effect. In contrast, the Src
inhibitor SU6656 only partially inhibited gene expres-
sion. This is consistent with the known redundancy of
MAPK signaling. Although many pathways that result
in ERK1/2 activation depend on Src family tyrosine ki-
nases, Src independent mechanisms also exist such as via
phosphoinositide 3-OH kinase [45, 58]. The Src tyrosine
kinases involved in the fibronectin induction of MCP-1
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as determined by immunoblotting in tubular epithelial cells (TECs) following fibronectin stimulation. (B) Effect of NF-jB inhibition with N-acetyl-
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mRNA expression following endotoxin stim-
ulation (10 or 100 EU/mL) at 6 hours
and response in the presence of polymyxin
B (RNase protection assay). Abbrevia-
tions are: RANTES, regulated upon activa-
tion, normal T-cell expressed and secreted;
MIP-2, macrophage inflammatory protein-2;
GAPDH, glyeraldehyde-3-phosphate dehy-
drogenase.
were not determined in this study. However, c-Src, Fyn,
or Yes are likely candidates since these are the only re-
ported Src tyrosine kinases expressed in the kidney [59,
60]. The role of NF-jB in the fibronectin induction of
MCP-1 is not surprising. First, most chemokine genes are
regulated at the transcriptional level by NF-jB. Second,
many studies examining the inflammatory effects of other
urinary proteins (e.g., albumin) and protein trafficking in
renal epithelium have found a role for NF-jB in the ac-
tivation of chemokine genes [4]. Therefore, our results
are consistent with the existing data regarding the tubu-
lar response to proteinuria. Of interest, both the MEK1/2
inhibitor, U0126, and the NF-jB antagonists (NAC and
PDTC) almost completely inhibited fibronectin induc-
tion of MCP-1. This suggests that ERK and NF-jB are
both necessary for the transcriptional activation of MCP-
1. While NF-jB has been linked to signaling via ERK1/2
in the proximal tubular response to albumin [23], the pos-
sible pleiotropic nature of chemical inhibitors must also
be considered. Further studies are required to dissect the
signaling and transcriptional mechanisms underlying the
fibronectin induction of MCP-1.
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Several small case series studies have documented in-
creased urinary fibronectin in patients with glomerular
disease. This includes diabetic nephropathy, membranous
nephropathy, and a variety of glomerular diseases associ-
ated with proteinuria [30–34]. The urinary concentration
of fibronectin was highly variable between these stud-
ies ranging from nanograms to micrograms per milliliter.
The discrepancy is likely a result of the different tech-
niques used to measure the various forms of the protein
(intact fibronectin vs. fragments) that may exist. Since
fibronectin undergoes proteolytic degradation in the kid-
ney [57], these studies may have underestimated the true
fibronectin content in urine if all possible fibronectin
forms were not detected in the respective assays. In this
study, we tested fibronectin concentrations starting at
50 ug/mL, which would be consistent with the human uri-
nary fibronectin levels measured in the study by Soyle-
mezoglu et al [34]. Despite these observational studies,
the clinical significance of urinary fibronectin excretion
remains to be determined.
In this study, we found significant endotoxin contami-
nation of most commercial fibronectin preparations (up
to 10 EU/mL in some cases). This introduced a signif-
icant confounding variable since tubular epithelial cells
are known to express endotoxin receptors TLR-2 and
TLR-4 [44]. To address this issue, we scrubbed endo-
toxin from fibronectin and experimental samples using
polymyxin B. To confirm that this procedure was effec-
tive, a number of control studies were performed (Fig. 7).
First, all polymyxin B–treated fibronectin was confirmed
to have less than 0.1 EU/mL of endotoxin as determined
by the limulus amebocyte lysate assay. Next, TEC re-
sponses to fibronectin and endotoxin were compared.
The induction of MCP-1 mRNA by fibronectin was unaf-
fected by polymyxin B (50 ug/mL) at 6 hours. In contrast,
polymyxin B completely inhibited chemokine mRNA in-
duction in response to a tenfold higher concentration of
endotoxin (100 EU/mL). Our study highlights the po-
tential pitfall of endotoxin contamination that must be
considered when tubular epithelial cell–stimulating ex-
periments are performed.
Our results provide new insight to the biology of re-
nal injury in glomerular disease and support the current
hypothesis regarding the effect of proteinuria on tubular
epithelium. While fibronectin may not be the predomi-
nant protein that results in the induction of inflammatory
genes, its presence may be additive to the tubular ep-
ithelial response to albumin and other more abundant
urinary proteins. Efforts should continue to reduce pro-
teinuria as a means to prevent renal failure in patients
with glomerular disease.
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